美国康奈尔大学医学院正在招收访问学者、博士后
2023/3/28 20:07:15 中国医学博士联络站
康奈尔大学(Cornell University)，又译作“康乃尔大学”，主校区位于美国纽约州伊萨卡，是美国境内的一所私立综合类研究型大学，为常春藤联盟成员校、国际大学气候联盟成员校、美国公立与赠地大学协会成员校 、美国大学协会的十四个创始院校之一 。
想要出国访问学习的小伙伴看过来啦，康奈尔大学医学院癌症生物学，生物化学，分子生物学，药理学，生物工程等相关研究方向正在招收访问学者、博士后!51访学网小编每周定时更新最新的访学招聘信息，感谢关注51访学。
Job Description
Position Summary:
The Molecular Imaging Innovations Institute (MI3) in the Department of Radiology at Weill Cornell Medicine, is seeking highly motivated postdoctoral/visiting scholar associates. The candidates will have the opportunity to train in a stimulating, demanding, and multi-disciplinary environment employing state-of-art preclinical/clinical imaging techniques to develop new drug delivery platforms and imaging probes for cancer treatments.
Responsibilities:
Develop a drug delivery system and new imaging method for treating cancer associated with the urinary system.
Investigate the heterogenous response of tumor microenvironment to chemotherapy, immunotherapy, and radiation therapy, using single-cell RNA-Seq and multimodal SPECT/PET/CT imaging approaches.
Develop new targeted peptides/proteins/antibodies using phage display technology
Qualifications include:
The candidate must hold a Ph.D. in a relevant discipline such as cancer biology, biochemistry, molecular biology, pharmacology, bioengineering, or an applicable related field and have a demonstrated publication track record.
Candidates with experience in immunotherapy, gene-editing, protein engineering, and preclinical cancer models are strongly encouraged to apply. The candidate will be expected to contribute to manuscript preparation and submission of proposals for funding.
Diversity is one of Weill Cornell Medicine’s core values and is essential to achieving excellence in patient care, research, and education. We welcome applications from candidates who share our commitment to fostering a culture of fairness, equity, and belonging. Weill Cornell Medicine is an Equal Employment Opportunity Employer, providing equal employment opportunities to all qualified applicants without regard to race, sex, sexual orientation, gender identity, national origin, color, age, religion, protected veteran or disability status, or genetic information.
Salary Range (annually): $62,400 – $72,800
To apply:
Interested applicants should send a curriculum vitae, bibliography, and a one-page statement of interest to:
Benedict Law, Ph.D.
Molecular Imaging Innovations Institute (MI3)
Department of Radiology, Weill Cornell Medicine
sbl2004@med.cornell.edu
About Us:
The Molecular Imaging Innovations Institute (MI3): Established in 2013, MI3 is committed to the further advancement of medical imaging technologies. MI3, an inter-disciplinary institute consisting of faculty, postdoctoral associates, and graduate students in physics, chemistry, biology, and medicine, is dedicated to the development of imaging probes and technologies that enable us to visualize disease at the molecular level. Our experts in various platform technologies, such as radiochemistry, nanotechnology, polymer, synthetic chemistry, optical imaging, medical physics, antibody, biology, engineering, and radiology, create innovative strategies to elucidate the biological mechanisms of health and disease.
Our research emphases are in the area of translational medicine related to oncology, cardiovascular diseases, neurologic and neuropsychiatric sciences, obesity research, and infectious diseases. The developed approaches are valid in the identification of diagnostic markers, detection of early disease states, derivation of treatment planning paradigms, validation of therapeutic effect, the development of guidance systems for minimally-invasive interventional / surgical procedures and finally the discovery of new drugs. MI3 is located in the new state of the art Belfer Research Building (BRB) in the heart of the tri-institutional campus (Weill Cornell Medicine (WCM), Memorial Sloan Kettering Cancer Center (MSKCC), and Rockefeller University) in New York City. The researchers at MI3 have unprecedented opportunities to collaborate with the scientists and clinicians at Weill Cornell Medicine, Memorial Sloan-Kettering Cancer Center, and Rockefeller University. Our collaborative environment serves as a nexus for pre-clinical and clinical translational programs. Using our unique advanced research resources, MI3 is able to fuel clinical imaging with therapeutic treatment. MI3’s mission is to drive innovation of new diagnostics and therapies from bench to bedside and to accelerate the development and transition of personalized medicine.
Weill Cornell Medicine: Founded in 1898, and affiliated with what is now New York-Presbyterian Hospital (NYPH)since 1927, Weill Cornell Medicine (WCM) is among the top-ranked clinical and medical research centers in the country. In addition to offering degrees in medicine, WCM also has PhD programs in biomedical research and education at the Weill Cornell Graduate School of Medical Sciences, and with neighboring Sloan-KetteringInstitute and The Rockefeller University, has established a joint MD-PhD program for students to intensify their pursuit of Weill Cornell's triple mission of education, research, and patient care.
WCM is divided into 24 basic science and patient care departments that focus on the sciences underlying clinical medicine and/or encompass the study, treatment, and prevention of human diseases. The basic science and clinical departments are located in buildings that straddle York Ave. between 68th and 72nd streets on Manhattan’s Upper East Side. Weill Cornell Medical College has 1781 full-time faculty (3582 total faculty) distributed across 8 basic science and 15 clinical departments. WCM maintains major affiliations with Memorial Sloan-Kettering Cancer Center, Rockefeller University, the Hospital for Special Surgery, as well as with the metropolitan-area institutions that constitute NYPHealthcare Network.
Weill Cornell Medicine is a comprehensive academic medical center that's committed to excellence in patient care, scientific discovery, and the education of future physicians in New York City and around the world. Our doctors and scientists-faculty from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, and the Weill Cornell Physician Organization-are engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Located in the heart of the Upper East Side's scientific corridor, Weill Cornell Medicine's powerful network of collaborators extends to its parent university Cornell University; to Qatar, where an international campus offers a U.S. medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Our medical practices serve communities throughout New York City, and our faculty provide comprehensive care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, NewYork-Presbyterian/Lower Manhattan Hospital, and NewYork-Presbyterian/Queens. At Weill Cornell Medicine, we work together to treat each individual, not just their conditions or illnesses, as we strive to deliver the finest possible care for our patients - the center of everything we do.
Weill Cornell Medicine is an Equal Employment Opportunity Employer. Weill Cornell Medicine provides equal employment opportunities to all qualified applicants without regard to race, sex, sexual orientation, gender identity, national origin, color, age, religion, protected veteran or disability status, or genetic information.
51访学网专注国外访问学者申请服务，已积累不计其数的成功访学案例，如麻省理工学院、哈佛大学、约翰霍普金斯大学、安德森癌症中心、梅奥诊所、麻省总医院、布莱根妇女医院、JHU医院、克利夫兰诊所等顶尖大学及医疗中心访学案例举不胜举。
因此，如果你对访学有所兴趣不妨试一下。希望我们能实现您访学的梦想!更多访学相关问题，请添加51访学专业咨询顾问于老师微信：woyaofangxue
想了解更多请点击阅读原文，留下您的联系方式，我们专业咨询顾问会和您联系~
51访学网精彩文章点击查看↓ ↓ ↓ ↓
2023年国家公派访问学者、博士后项目选派办法
国家公派访学延迟出国及改派指南
CSC留学基金委派出手续违约及处罚相关条款
医生访学需要准备什么材料？什么手续？
CSC公派申请教程-史上最全!(附资料分享)
CSC公派访问学者申请表如何填写？
出国访学获得公派资助后，需要办理哪些事项？
手把手教你申请德国访学签证，最全攻略来了～
51访学网访学案例点击查看 ↓ ↓ ↓ ↓
哈佛大学｜梅奥诊所｜克利夫兰｜麻省总医院｜加州大学洛杉矶分校｜加州大学旧金山分校｜匹兹堡大学｜西北大学｜康奈尔大学｜帝国理工大学｜伦敦国王学院｜ 南洋理工大学｜诺丁汉大学｜海德堡大学｜柏林自由大学｜东京医科大学
点击“阅读原文”名校访学免费评估哦~
源网页 http://weixin.100md.com
返回 中国医学博士联络站 返回首页 返回百拇医药